Morbilliform rashes in a patient with COVID-19 infection: A case report
As the current COVID-19 pandemic is evolving, skin lesions are being reported more, the most common skin manifestation being morbilliform rashes. We describe a patient of severe COVID-19 infection, 48-year-old who initially presented with fever, cough and constitutional symptoms who developed morbi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nepal Medical Association
2021-04-01
|
Series: | Journal of Nepal Medical Association |
Subjects: | |
Online Access: | http://www.jnma.com.np/jnma/index.php/jnma/article/view/5128 |
id |
doaj-4d3f969e944a44a5a40b5b6edb2c6a21 |
---|---|
record_format |
Article |
spelling |
doaj-4d3f969e944a44a5a40b5b6edb2c6a212021-05-16T10:32:35ZengNepal Medical AssociationJournal of Nepal Medical Association0028-27151815-672X2021-04-015923610.31729/jnma.5128Morbilliform rashes in a patient with COVID-19 infection: A case report Kiran Ghimire0Nabin Adhikari1Shree Birendra Hospital, Chhauni, Kathmandu, NepalShree Birendra Hospital, Chhauni, Kathmandu, Nepal. As the current COVID-19 pandemic is evolving, skin lesions are being reported more, the most common skin manifestation being morbilliform rashes. We describe a patient of severe COVID-19 infection, 48-year-old who initially presented with fever, cough and constitutional symptoms who developed morbilliform macular rashes during his illness. The rash appeared on 6th day of illness in the trunk, arms with sparing of palms and soles, associated with itching. He later developed features of the cytokine-storm syndrome. The exact mechanism for the rashes is yet to be elaborated, however, it is postulated that it is either due to immune-mediated vasodilation or micro thrombosis secondary to low-grade-coagulopathy associated with COVID-19. Recognition of rashes as a feature of this disease is particularly significant to clinicians as it aids in early diagnosis, particularly in resource-poor countries. There is no evident association, however, between the severity and the rashes in COVID-19 infection. http://www.jnma.com.np/jnma/index.php/jnma/article/view/5128coagulopathy; COVID-19; cytokine release syndrome; D-dimer; morbilliform. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kiran Ghimire Nabin Adhikari |
spellingShingle |
Kiran Ghimire Nabin Adhikari Morbilliform rashes in a patient with COVID-19 infection: A case report Journal of Nepal Medical Association coagulopathy; COVID-19; cytokine release syndrome; D-dimer; morbilliform. |
author_facet |
Kiran Ghimire Nabin Adhikari |
author_sort |
Kiran Ghimire |
title |
Morbilliform rashes in a patient with COVID-19 infection: A case report |
title_short |
Morbilliform rashes in a patient with COVID-19 infection: A case report |
title_full |
Morbilliform rashes in a patient with COVID-19 infection: A case report |
title_fullStr |
Morbilliform rashes in a patient with COVID-19 infection: A case report |
title_full_unstemmed |
Morbilliform rashes in a patient with COVID-19 infection: A case report |
title_sort |
morbilliform rashes in a patient with covid-19 infection: a case report |
publisher |
Nepal Medical Association |
series |
Journal of Nepal Medical Association |
issn |
0028-2715 1815-672X |
publishDate |
2021-04-01 |
description |
As the current COVID-19 pandemic is evolving, skin lesions are being reported more, the most common skin manifestation being morbilliform rashes. We describe a patient of severe COVID-19 infection, 48-year-old who initially presented with fever, cough and constitutional symptoms who developed morbilliform macular rashes during his illness. The rash appeared on 6th day of illness in the trunk, arms with sparing of palms and soles, associated with itching. He later developed features of the cytokine-storm syndrome. The exact mechanism for the rashes is yet to be elaborated, however, it is postulated that it is either due to immune-mediated vasodilation or micro thrombosis secondary to low-grade-coagulopathy associated with COVID-19. Recognition of rashes as a feature of this disease is particularly significant to clinicians as it aids in early diagnosis, particularly in resource-poor countries. There is no evident association, however, between the severity and the rashes in COVID-19 infection.
|
topic |
coagulopathy; COVID-19; cytokine release syndrome; D-dimer; morbilliform. |
url |
http://www.jnma.com.np/jnma/index.php/jnma/article/view/5128 |
work_keys_str_mv |
AT kiranghimire morbilliformrashesinapatientwithcovid19infectionacasereport AT nabinadhikari morbilliformrashesinapatientwithcovid19infectionacasereport |
_version_ |
1721439908371890176 |